Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine, Rochester, MN.
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine, Rochester, MN.
J Cardiothorac Vasc Anesth. 2020 Jun;34(6):1446-1456. doi: 10.1053/j.jvca.2019.12.049. Epub 2020 Jan 7.
Assess outcomes after intraoperative plasma transfusion in patients undergoing cardiac surgery.
Retrospective study of adult cardiac surgical between 2011 and 2015. Relationships between plasma transfusion volume, coagulation test values, and a primary outcome of early postoperative red blood cell (RBC) transfusion were assessed via multivariable regression analyses. Secondary outcomes included hospital mortality, intensive care unit and hospital-free days, intraoperative RBCs, estimated blood loss, and reoperation for bleeding.
Academic tertiary referral center.
A total of 1,794 patients received intraoperative plasma transfusions during the study period.
None.
Higher plasma transfusion volumes were associated with worse clinical outcomes, with each 1-unit increase being associated with greater odds for postoperative RBCs [odds ratio (OR) 1.12 (confidence interval [CI] 1.04-1.20); p = 0.002], intraoperative [OR 1.85 (CI 1.69-2.03); p < 0.001], and fewer hospital-free days [mean -0.20 (-0.39, -0.01); p = 0.04]. Each 0.1 increase in pretransfusion International Normalized Ratio (INR) was associated with increased odds of postoperative and intraoperative RBCs, reoperation for bleeding, and fewer intensive care unit and hospital-free days. For given plasma volumes, patients achieving greater reduction in elevated pretransfusion INR values experienced more favorable outcomes.
In patients undergoing cardiac surgery who received intraoperative plasma transfusion, higher plasma transfusion volumes were associated with inferior clinical outcomes. Higher pretransfusion INR values also were associated with worse outcomes; however, those achieving a greater degree of INR correction after plasma transfusion demonstrated more favorable outcomes. Prospective studies related to plasma transfusion are needed to address this important topic.
评估心脏手术患者术中血浆输注的结果。
对 2011 年至 2015 年间成人心脏手术的回顾性研究。通过多变量回归分析评估血浆输注量、凝血试验值与术后早期红细胞(RBC)输注的主要结果之间的关系。次要结果包括院内死亡率、重症监护病房和住院无天数、术中 RBC、估计失血量和因出血再次手术。
学术三级转诊中心。
共有 1794 名患者在研究期间接受了术中血浆输注。
无。
较高的血浆输注量与较差的临床结果相关,每增加 1 个单位,术后 RBC 的几率就会增加[比值比(OR)1.12(95%置信区间[CI]1.04-1.20);p=0.002]、术中[OR 1.85(CI 1.69-2.03);p<0.001]和住院无天数减少[平均-0.20(-0.39,-0.01);p=0.04]。每个 0.1 国际标准化比值(INR)的增加与术后和术中 RBC、因出血再次手术以及重症监护病房和住院无天数减少的几率增加相关。对于给定的血浆量,达到更高的术前 INR 值降低的患者经历了更有利的结果。
在接受术中血浆输注的心脏手术患者中,较高的血浆输注量与较差的临床结果相关。较高的术前 INR 值也与较差的结果相关;然而,在接受血浆输注后 INR 校正程度更高的患者表现出更好的结果。需要前瞻性研究来解决这个重要的问题。